Logo

Cellomics Rounds up $15 Million in Financing

Sep 11, 2002

NEW YORK, Sept. 11-Screening tool and bioinformatics company Cellomics said last week that it had completed a round of financing that brought in $15 million.

 

Investors include the German optics and microscopy company Carl Zeiss, joined by Oxford Bioscience Partners, the Vector Fund, Alta Partners, and Axiom Ventures.

 

Zeiss was Cellomics' initial seed investor, and the two companies have collaborated to develop a high-throughput screening platform for lead optimization, target validation and toxicology.

 

For more information, see the press release.

Breaking News
The Scan

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.

Seagull Microbiome Altered by Microplastic Exposure

The overall diversity and the composition at gut microbiome sites appear to coincide with microplastic exposure and ingestion in two wild bird species, according to a new Nature Ecology and Evolution study.

Study Traces Bladder Cancer Risk Contributors in Organ Transplant Recipients

In eLife, genome and transcriptome sequencing reveal mutation signatures, recurrent somatic mutations, and risky virus sequences in bladder cancers occurring in transplant recipients.

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.